Hologic Q1 Revenues Grow 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Hologic reported after the close of the market Wednesday that revenues for its fiscal first quarter were up about 7 percent year over year driven in part by growth in its diagnostics and molecular diagnostics businesses. 

The Bedford, Massachusetts-based firm reported total revenues of $695.2 million for the quarter ended Dec. 26, up from $652.8 million in the prior year and above the Wall Street estimate of $688 million. On a constant currency basis, Q1 revenues grew 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.